Developing non-opiate gpcr signaling-biased agents for pain management
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210267
- Recipient
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,608,140
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Durham, NC 27708, USA
Award details come from USAspending.gov.
About this award
Duke University was awarded a $1,608,140 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to develop non-opioid G protein-coupled receptor signaling-biased agents for pain management. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield medicine. Duke University will leverage this funding to conduct research on developing alternative treatments to opioids for pain management over the four-year period of performance.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $1,608,140 |
Quick answers
Who received award W81XWH2210267?
W81XWH2210267 was awarded to Duke University by Medical Command (Department of the Army) on September 1, 2022.
How much is award W81XWH2210267 worth?
$1,608,140 has been obligated on W81XWH2210267.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award